FXS0887 / Fosun Pharma - LARVOL DELTA

Global research and development | Fosun Medicine self-developed small molecule innovative drug FXS0887 approved clinical treatment of advanced malignant solid tumors [Google translation] (Fosun Pharma Press Release) - "Recently, Fosun Pharmaceutical...received the approval of the State Drug Administration...[for] the clinical trial of FXS887 tablets...for advanced malignant solid tumors. Fosun Pharmaceutical Industry intends to carry out Phase I clinical trials of FXS0887 in China after the conditions are met."

New P1 trial • Solid Tumor